Trafalgar International (GCAN) Net Cash Flow (2017 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Net Cash Flow of $624.0 for Q1 2026, up 105.59% year-over-year from $303.51 in Q1 2025, and up 102.58% quarter-over-quarter from -$24140.0 in Q4 2025.
Trafalgar International (GCAN) Net Cash Flow (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Net Cash Flow history runs 10 years deep, the most recent figure standing at $624.0 for Q1 2026.
- In Q1 2026, Net Cash Flow rose 105.59% year-over-year to $624.0; the TTM figure through Mar 2026 stood at -$48374.0 (up 41.8% YoY), while the FY2025 annual figure was -$56553.0, up 48.35% from the prior year.
- Net Cash Flow for Q1 2026 stood at $624.0, up from -$24140.0 in the prior quarter.
- The five-year high for Net Cash Flow was $624.0 in Q1 2026, with the low at -$56392.0 in Q2 2022.
- The 5-year median for Net Cash Flow is -$19064.0 (2022), against an average of -$22334.2.
- The sharpest annual moves came in 2025 and 2026: Net Cash Flow tumbled 391.25% in 2025, then soared 105.59% in 2026.
- Greater Cannabis Company's Net Cash Flow stood at -$19064.0 in 2022, then slumped by 71.39% to -$32673.0 in 2023, then jumped by 84.96% to -$4914.0 in 2024, then slumped by 391.25% to -$24140.0 in 2025, then surged by 102.58% to $624.0 in 2026.
- Business Quant data shows GCAN's Net Cash Flow at $624.0 in Q1 2026, -$24140.0 in Q4 2025, and -$5357.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | 624.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 624.00 |
| Mar 31, 2026 | 624.00 |
| Dec 31, 2025 | -24,140.00 |
| Dec 31, 2025 | -24,140.00 |
| Sep 30, 2025 | -5,357.00 |
| Sep 30, 2025 | -5,357.00 |
| Jun 30, 2025 | -19,501.00 |
| Jun 30, 2025 | -19,501.00 |
| Mar 31, 2025 | -11,155.00 |
| Mar 31, 2025 | -11,155.00 |
| Dec 31, 2024 | -4,914.00 |
| Dec 31, 2024 | -4,914.00 |
| Sep 30, 2024 | -18,034.00 |
| Sep 30, 2024 | -18,034.00 |
| Jun 30, 2024 | -49,007.00 |
| Jun 30, 2024 | -49,007.00 |
| Mar 31, 2024 | -37,536.00 |
| Mar 31, 2024 | -37,536.00 |
| Dec 31, 2023 | -32,673.00 |
| Dec 31, 2023 | -32,673.00 |